No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bone Rep
Egile Nagusiak: Misof, Barbara M., Roschger, Paul, Zhou, Hua, Nieves, Jeri W., Bostrom, Mathias, Cosman, Felicia, Lindsay, Robert, Klaushofer, Klaus, Dempster, David W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7090359/
https://ncbi.nlm.nih.gov/pubmed/32215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100253
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak